Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Neurourol Urodyn. 2018 Aug;37(6):1897-1903. doi: 10.1002/nau.23547. Epub 2018 Mar 6.
We investigated the effects of silodosin, an α1A-adrenoceptor (AR) antagonist, on bladder function, especially on non-voiding contractions (NVCs), in a male rat model of bladder outlet obstruction (BOO) by evaluating cystometry (CMG) findings and bladder mechanosensitive single-unit afferent activities (SAAs), related with microcontractions, which may be similar with NVCs and to be of myogenic origin, in the rat model.
BOO was created by partial ligation of the posterior urethra. At 4 days after surgery for BOO, an osmotic pump filled with silodosin (0.12 mg/kg/day) or its vehicle was subcutaneously implanted. At 10 days after surgery, CMG and SAAs measurements were taken under conscious and urethane-anesthetized conditions, respectively. The SAAs of Aδ- and C-fibers, which were identified by electrical stimulation of the pelvic nerve and by bladder distention, and intravesical pressure were recorded during constant bladder-filling with saline. Microcontractions were divided into three phases: "ascending," "descending," and "stationary."
The silodosin-treated group showed a smaller number of NVCs in CMG measurements and lower SAAs of both Aδ- and C-fibers than the vehicle-treated group during bladder-filling. Moreover, in the vehicle-treated groups, the SAAs of both fibers for the ascending phase of microcontractions were significantly higher than those for the other two phases. On the contrary, no significant change was found between any of these three phases in the silodosin-treated group.
The present results suggest that silodosin inhibits the SAAs of mechanosensitive Aδ- and C-fibers at least partly due to suppressing myogenic bladder contractions in male BOO rats.
通过评估膀胱测压(CMG)结果和与微收缩相关的膀胱机械敏感单单位传入活动(SAAs),我们研究了α1A-肾上腺素能受体(AR)拮抗剂西洛多辛对膀胱功能的影响,特别是对雄性膀胱出口梗阻(BOO)大鼠模型中非排空收缩(NVC)的影响。在该大鼠模型中,SAAs 与微收缩有关,可能与 NVC 相似,且具有肌源性起源。
通过部分结扎后尿道来建立 BOO。在 BOO 手术后 4 天,通过皮下植入装有西洛多辛(0.12mg/kg/天)或其载体的渗透泵。在手术后 10 天,在清醒和乌拉坦麻醉条件下分别进行 CMG 和 SAAs 测量。通过对阴部神经进行电刺激和膀胱扩张来识别 Aδ-和 C-纤维的 SAAs,并在恒压盐水充盈膀胱期间记录膀胱内压。微收缩分为三个阶段:“上升”、“下降”和“静止”。
与载体处理组相比,西洛多辛处理组在 CMG 测量中显示出较少的 NVC,并且在膀胱充盈期间,Aδ-和 C-纤维的 SAAs 也较低。此外,在载体处理组中,微收缩上升阶段的两种纤维的 SAAs 均明显高于其他两个阶段。相反,在西洛多辛处理组中,这三个阶段之间没有发现明显变化。
本研究结果表明,西洛多辛通过抑制雄性 BOO 大鼠的肌源性膀胱收缩,至少部分抑制了机械敏感的 Aδ-和 C-纤维的 SAAs。